Geopolitical uncertainty is changing how healthcare organizations evaluate MedTech suppliers. Price remains important, but procurement teams are increasingly looking beyond acquisition cost to assess supply continuity, lifecycle value, regulatory readiness, service capability, and the ability to manage disruption.

In From Price to Resilience: How Geopolitical Uncertainty Is Reshaping MedTech Procurement, IQVIA MedTech examines how purchasing models are evolving across markets and product categories, and what these changes mean for MedTech manufacturers.

The white paper explores five MedTech purchasing archetypes, from price-led commodity procurement to outcome-led, integrated partnerships, and identifies four dimensions where geopolitical uncertainty is changing purchasing behavior: decision-making, contracting and pricing, scope of the offering, and the evidence required for adoption.

Inside the white paper, discover:

• How geopolitical uncertainty is influencing MedTech procurement decisions
• Why procurement criteria are shifting from price toward risk-adjusted value
• How supply resilience, sourcing transparency and regulatory readiness can influence supplier selection
• How procurement models differ across regions, healthcare systems and device categories
• Five priorities MedTech companies should consider to make resilience a commercial capability